Stockscreener 앱 받기
2.80
0.36%
0.010
시간 외 거래:
2.80
전일 마감가:
$2.79
열려 있는:
$2.81
하루 거래량:
518.09K
Relative Volume:
0.68
시가총액:
$204.78M
수익:
$405.47M
순이익/손실:
$53.66M
주가수익비율:
3.8889
EPS:
0.72
순현금흐름:
$131.28M
1주 성능:
-10.26%
1개월 성능:
-9.68%
6개월 성능:
-25.13%
1년 성능:
-31.87%
1일 변동 폭
$2.745
$2.90
1주일 범위
$2.66
$3.195
52주 변동 폭
$2.36
$4.61
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
OSUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.80 | 204.05M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
478.19 | 169.15B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
194.96 | 55.18B | 21.39B | 1.59B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
86.03 | 41.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
283.29 | 41.63B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
239.90 | 17.28B | 2.90B | 467.20M | 306.90M | 6.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
OraSure Technologies Inc. Recovery Hinges on Volume BreakoutLow Capital High Return Stock Plans Reviewed - 선데이타임즈
David Nierenberg Exits Cantaloupe Inc, Portfolio Down 10.6% - AInvest
OraSure Technologies Inc. stock prediction for this weekAI-Based Stock Behavior Forecast Engine - Newser
Is this a good reentry point in OraSure Technologies Inc.Free Value Investing Picks With Stability - Newser
Visualizing OraSure Technologies Inc. stock with heatmapsFree Pattern Breakout Entry Stock Forecast - Newser
Risk adjusted return profile for OraSure Technologies Inc. analyzedSwing Trade Picks with High Potential - Newser
OraSure Technologies, Inc. (NASDAQ:OSUR) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
What momentum shifts mean for OraSure Technologies Inc.Equity Performance Forecast Based on AI Models - Newser
Why OraSure Technologies Inc. stock attracts strong analyst attentionFree Weekly Setup With 3x Return Potential - Newser
OraSure Technologies, Inc. (NASDAQ:OSUR) Q2 2025 Earnings Call Transcript - Insider Monkey
OraSure (OSUR) Q2 Revenue Falls 43% - AOL.com
OraSure Technologies Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Orasure Technologies 2025 Q2 Earnings Deepened Losses Amid Sharp Revenue Drop - AInvest
OraSure Q2 Earnings Call: Revenue Growth, Innovation Progress, and Challenges Ahead - AInvest
OraSure reports second quarter earnings amid 'continued uncertainty' - WFMZ.com
OraSure Technologies Q2 2025 Earnings: Revenue Down 43%, EPS Misses Expectations - AInvest
OraSure Reports Q2 Earnings in Line with Expectations, Raises Novel Blood Collection Device for Proteomic Research - AInvest
OraSure Technologies Q2 Financial Results: $19.7 Million LossNews and Statistics - IndexBox
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition - MSN
OraSure Technologies Inc (OSUR) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
OraSure: Q2 Earnings Snapshot - Greenwich Time
OraSure Technologies Reports Q2 2025 Financial Results - TipRanks
OraSure's Strategic Transformation: A High-Conviction Play in the Evolving Diagnostics Sector - AInvest
OraSure's Q2 2025: Unpacking Key Contradictions in Margins, Demand, and Revenue Outlook - AInvest
OraSure Q3 Revenue Outlook Revised to $27M-$30M Amid New Proteomics Product Launch and Manufacturing Transition Completion. - AInvest
OraSure’s Covid Come-Down Triggers Revenue Drop, But Outlook Brightens - Finimize
Transcript : OraSure Technologies, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: OraSure Q2 2025 results show mixed performance By Investing.com - Investing.com South Africa
Earnings call transcript: OraSure Q2 2025 results show mixed performance - Investing.com India
OraSure Technologies (OSUR) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
OraSure Technologies Q2 Earnings: -$19.69mln, -$0.26 EPS, $31.24mln Revenue - AInvest
OraSure Technologies Inc reports results for the quarter ended June 30Earnings Summary - TradingView
OraSure Q2 Revenue Down 43% Amidst Appointments and M&A Activity - AInvest
OraSure Q2 revenue falls 43% - MarketScreener
OraSure Technologies Reports 43% Revenue Decline in Q2 2025 - TipRanks
OraSure Announces Second Quarter 2025 Financial Results - GlobeNewswire
RENEW 8-K: Ninth SPAC Extension Adds $250k to Trust, Deadline Sep 5 2025 | OSUR SEC FilingForm 8-K - Stock Titan
CRISPR-Based Diagnostics Market Driven by Rapid Detection - openPR.com
OraSure Appoints Anne Messing as Chief Commercial Officer - The Manila Times
Wave Life Sciences Ltd. shares rise 6.03% premarket after OraSure Technologies appoints new Chief Commercial Officer. - AInvest
What analysts say about OraSure Technologies Inc. stockInvest smarter with actionable trading signals - Jammu Links News
How volatile is OraSure Technologies Inc. stock compared to the marketAchieve superior returns through strategic trading - Jammu Links News
What makes OraSure Technologies Inc. stock price move sharplyInvest confidently with real-time market updates - Jammu Links News
What institutional investors are buying OraSure Technologies Inc. stockFree Stock Market Query - Jammu Links News
Why OraSure Technologies Inc. is moving todayExpert-Backed High Yield Stock Watchlist - Newser
What is the risk reward ratio of investing in OraSure Technologies Inc. stockUnlock exclusive stock market forecasts - Jammu Links News
How many analysts rate OraSure Technologies Inc. as a “Buy”Extraordinary profit generation - Jammu Links News
OraSure Technologies Inc. Approaches Psychological Resistance LevelPotential Breakout Stock List Published This Week - beatles.ru
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.21%
0.06%
자본화:
|
볼륨(24시간):